Atlas Trials

Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD

Clinical trial NCT06969573 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06969573
Sponsor
University of Alberta
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
COPD (Chronic Obstructive Pulmonary Disease)
Start date
2025-06-05
Primary completion
2026-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.